US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

46.32

+0.14000.30%

Volume:74.58K

Turnover:3.47M

Market Cap:1.57B

PE:22.26

High:47.42

Open:46.01

Low:45.85

Close:46.18

52wk High:60.00

52wk Low:39.58

Shares:34.00M

Float Shares:27.67M

Volume Ratio:1.95

T/O Rate:0.27%

Dividend:2.99

Dividend Rate:6.46%

EPS(TTM):2.08

EPS(LYR):2.41

ROE:13.77%

ROA:3.98%

PB:2.60

PE(LYR):19.22

Loading ...

Overview Company News Filings

Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era

Regulatory Overhang on Compounded GLP‑1 Drives Hold Rating and Lowered Outlook for Hims & Hers

Dow Jones Top Company Headlines at 1 AM ET: Health Agency Refers Knockoff GLP-1 Provider Hims & Hers to Justice Department | Innovent ...

Dow Jones Top Company Headlines at 7 PM ET: FDA Targets Hims & Hers, Other Marketers of Unapproved GLP-1 Weight-Loss Drugs | Justice ...

FDA intends to ‘take action’ against non-FDA-approved GLP-1 drugs

Embecta: Stable Execution, GLP-1–Driven Growth Optionality, and Attractive Valuation Support Buy Rating and $25 Target

LifeVantage Earnings Call: GLP-1 Hit Tests Turnaround

Edible Garden to Participate in ECRM’s Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, February 10–12, 2026

Press Release: GLP China Holdings Limited TENDER OFFER TO PURCHASE FOR CASH ANY AND ALL OF ITS U.S.$700,000,000 2.95 PER CENT. NOTES DUE 2026

PepsiCo Charts Growth Amid GLP-1, Ad Headwinds

Is It Time To Reassess Global Partners (GLP) After Big Five Year Share Gains?

Simply Wall St.

Press Release: Global Partners Declares Fourth-Quarter 2025 Cash Distribution of $0.7600 on Common Units

Fractyl Health Advances Revita for Post-GLP-1 Weight Maintenance

Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users

Huadong Medicine: HDM1002, as a differentiated oral GLP-1 targeted drug, is positioned to meet unmet and differentiated clinical needs in the global market

Roche Reports Positive Phase II Trial Results for GLP-1/GIP Dual Receptor Drug

ASCLETIS-B (01672) Announces Completion of First Dosing in 13-Week US Phase II Study of Oral Small-Molecule GLP-1R Agonist ASC30 for Diabetes

Ascletis Starts U.S. Phase II Diabetes Trial of Oral GLP-1 Drug ASC30 After Strong Obesity Data

ASCLETIS-B (01672) Selects Next-Generation Monthly Subcutaneous GLP-1R/GIPR/GCGR Triple Agonist Peptide ASC37 for Clinical Development

Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GLP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners LP","latestPrice":46.32,"timestamp":1770670800000,"preClose":46.18,"halted":0,"volume":74583,"delay":0,"changeRate":0.0030316154179298523,"floatShares":27674174,"shares":33995563,"eps":2.080802,"marketStatus":"Pre-Mkt","change":0.14,"latestTime":"02-10 09:10:55 EST","open":46.01,"high":47.42,"low":45.85,"amount":3473789.74128,"amplitude":0.033997,"askPrice":62.59,"askSize":300,"bidPrice":39,"bidSize":7,"shortable":3,"etf":0,"ttmEps":2.080802,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":46.32,"dividendRate":0.064551,"postHourTrading":{"tag":"盘后","latestPrice":47.2,"preClose":46.32,"latestTime":"19:20 EST","volume":1472,"amount":68433.04,"timestamp":1770682813799,"change":0.88,"changeRate":0.018998,"amplitude":0.011874},"volumeRatio":1.948191379359642,"impliedVol":0.3607,"impliedVolPercentile":0.56},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":27674174,"roa":"3.98%","roe":"13.77%","lyrEps":2.41,"volumeRatio":1.948191379359642,"shares":33995563,"dividePrice":2.99,"high":47.42,"amplitude":0.033997,"preClose":46.18,"low":45.85,"week52Low":39.58,"pbRate":"2.60","psRate":"0.09","week52High":60,"institutionHeld":0.4714,"latestPrice":46.32,"committee":-0.954397,"eps":2.080802,"divideRate":0.064551,"volume":74583,"delay":0,"ttmEps":2.080802,"open":46.01,"prevYearClose":41.85,"prevWeekClose":46.94,"prevMonthClose":47.22,"prevQuarterClose":41.85,"fiveDayClose":46.54,"twentyDayClose":42.64,"sixtyDayClose":41.98,"dividendPayoutRate":1.1692368072476331,"dividendFrequency":"Q","dividendGrowthYears":0,"dividendGrowthRate":-0.20278745644599305,"fiveYearAvgDividendRate":0.09217143297642297},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"date":"2026-02-09","symbol":"GLP","amount":0.76,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-09","defaultRemindTime":1770647400000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-13","payableDate":"2026-02-09","currency":"USD","dateTimestamp":1770613200000,"payDate":"2026-02-13"},{"date":"2025-11-10","symbol":"GLP","amount":0.755,"announcedDate":"2025-10-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-10","defaultRemindTime":1762785000000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-14","payableDate":"2025-11-10","currency":"USD","dateTimestamp":1762750800000,"payDate":"2025-11-14"},{"market":"US","date":"2025-11-07","symbol":"GLP","fiscalQuarterEnding":"2025/09","expectedEps":1.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":0.66},{"date":"2025-08-08","symbol":"GLP","amount":0.75,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-08","defaultRemindTime":1754659800000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-08-08","currency":"USD","dateTimestamp":1754625600000,"payDate":"2025-08-14"},{"market":"US","date":"2025-08-07","symbol":"GLP","fiscalQuarterEnding":"2025/06","expectedEps":0.6,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0.55}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2016-05-04","recordDate":"2016-05-06","paymentDate":"2016-05-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-08-04","recordDate":"2016-08-08","paymentDate":"2016-08-12","value":0.4625,"currency":"USD"},{"executeDate":"2016-11-04","recordDate":"2016-11-08","paymentDate":"2016-11-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-02-07","recordDate":"2017-02-09","paymentDate":"2017-02-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-05-08","recordDate":"2017-05-10","paymentDate":"2017-05-15","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1741237200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2026-02-09","current":22.260648,"percent":0.916533,"low":2.771386,"twenty":4.440923,"median":12.42954,"eighty":17.957066,"high":29.34912,"avg":12.011409,"sd":6.430804,"marketCap":1587784882},"quantilePoints":[{"date":"2021-02-12","current":6.934229,"twenty":6.163202,"median":7.760634,"eighty":11.053134,"marketCap":664084222},{"date":"2021-02-19","current":7.112763,"twenty":6.167321,"median":7.75285,"eighty":11.04396,"marketCap":681182168},{"date":"2021-02-26","current":7.202029,"twenty":6.167844,"median":7.741174,"eighty":11.038761,"marketCap":689731141},{"date":"2021-03-05","current":6.896217,"twenty":6.167844,"median":7.718575,"eighty":11.032407,"marketCap":695214499},{"date":"2021-03-12","current":7.842623,"twenty":6.167844,"median":7.698362,"eighty":11.017031,"marketCap":790622686},{"date":"2021-03-19","current":7.720506,"twenty":6.167844,"median":7.718575,"eighty":11.007626,"marketCap":778311953},{"date":"2021-03-26","current":7.411822,"twenty":6.167844,"median":7.69367,"eighty":11.00501,"marketCap":747193153},{"date":"2021-04-01","current":7.320234,"twenty":6.167844,"median":7.686686,"eighty":10.988222,"marketCap":737960103},{"date":"2021-04-09","current":7.3779,"twenty":6.167844,"median":7.67501,"eighty":10.954813,"marketCap":743773505},{"date":"2021-04-16","current":7.510194,"twenty":6.168749,"median":7.659442,"eighty":10.940212,"marketCap":757110133},{"date":"2021-04-23","current":7.364332,"twenty":6.170107,"median":7.594997,"eighty":10.930856,"marketCap":742405645},{"date":"2021-04-30","current":8.185229,"twenty":6.171613,"median":7.641929,"eighty":10.912383,"marketCap":825161134},{"date":"2021-05-07","current":9.181725,"twenty":6.178654,"median":7.67501,"eighty":10.905455,"marketCap":849502414},{"date":"2021-05-14","current":8.749253,"twenty":6.185826,"median":7.686686,"eighty":10.905455,"marketCap":809489619},{"date":"2021-05-21","current":9.203903,"twenty":6.185826,"median":7.690578,"eighty":10.897433,"marketCap":851554353},{"date":"2021-05-28","current":9.407203,"twenty":6.185826,"median":7.712361,"eighty":10.877257,"marketCap":870363786},{"date":"2021-06-04","current":9.706607,"twenty":6.189262,"median":7.720506,"eighty":10.864653,"marketCap":898064952},{"date":"2021-06-11","current":10.061456,"twenty":6.203126,"median":7.741174,"eighty":10.858681,"marketCap":930895963},{"date":"2021-06-18","current":9.603109,"twenty":6.203644,"median":7.748958,"eighty":10.836624,"marketCap":888489240},{"date":"2021-06-25","current":9.680732,"twenty":6.203808,"median":7.760634,"eighty":10.817799,"marketCap":895671024},{"date":"2021-07-02","current":9.658554,"twenty":6.203808,"median":7.768418,"eighty":10.809851,"marketCap":893619086},{"date":"2021-07-09","current":9.31849,"twenty":6.203808,"median":7.778148,"eighty":10.796921,"marketCap":862156033},{"date":"2021-07-16","current":8.963641,"twenty":6.213362,"median":7.780094,"eighty":10.785892,"marketCap":829325022},{"date":"2021-07-23","current":9.495915,"twenty":6.213362,"median":7.785616,"eighty":10.763835,"marketCap":878571539},{"date":"2021-07-30","current":9.909906,"twenty":6.216526,"median":7.795662,"eighty":10.752807,"marketCap":916874385},{"date":"2021-08-06","current":29.34912,"twenty":6.22179,"median":7.817068,"eighty":10.752807,"marketCap":823536295},{"date":"2021-08-13","current":26.023372,"twenty":6.22179,"median":7.822906,"eighty":10.813084,"marketCap":730215805},{"date":"2021-08-20","current":24.554702,"twenty":6.22179,"median":7.83069,"eighty":10.865043,"marketCap":689004931},{"date":"2021-08-27","current":24.530426,"twenty":6.22179,"median":7.834582,"eighty":10.905455,"marketCap":688323760},{"date":"2021-09-03","current":25.100901,"twenty":6.22179,"median":7.842494,"eighty":10.964493,"marketCap":704331289},{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":15.403069,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1642136538},{"date":"2024-06-07","current":15.399881,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1641796762},{"date":"2024-06-14","current":15.042931,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1603741870},{"date":"2024-06-21","current":14.389583,"twenty":4.452456,"median":8.72747,"eighty":13.257384,"marketCap":1534087827},{"date":"2024-06-28","current":14.542562,"twenty":4.452456,"median":8.72747,"eighty":13.270766,"marketCap":1550397066},{"date":"2024-07-05","current":14.395957,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1534767378},{"date":"2024-07-12","current":13.586443,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1448464320},{"date":"2024-07-19","current":12.767369,"twenty":4.452456,"median":8.72747,"eighty":13.228966,"marketCap":1361141934},{"date":"2024-07-26","current":12.910786,"twenty":4.452456,"median":8.72747,"eighty":13.052045,"marketCap":1376431846},{"date":"2024-08-02","current":13.302795,"twenty":4.452456,"median":8.72747,"eighty":12.924809,"marketCap":1418224272},{"date":"2024-08-09","current":12.449802,"twenty":4.452456,"median":8.72747,"eighty":12.75462,"marketCap":1335540014},{"date":"2024-08-16","current":13.196601,"twenty":4.452456,"median":8.72747,"eighty":12.789678,"marketCap":1415652134},{"date":"2024-08-23","current":13.473893,"twenty":4.452456,"median":8.72747,"eighty":13.02799,"marketCap":1445398406},{"date":"2024-08-30","current":14.204937,"twenty":4.452456,"median":8.72747,"eighty":13.191559,"marketCap":1523820396},{"date":"2024-09-06","current":13.316341,"twenty":4.452456,"median":8.72747,"eighty":13.222287,"marketCap":1428497115},{"date":"2024-09-13","current":13.558971,"twenty":4.452456,"median":8.72747,"eighty":13.305504,"marketCap":1454525103},{"date":"2024-09-20","current":14.226994,"twenty":4.452456,"median":8.72747,"eighty":13.395117,"marketCap":1526186577},{"date":"2024-09-27","current":14.085197,"twenty":4.452456,"median":8.72747,"eighty":13.544476,"marketCap":1510975415},{"date":"2024-10-04","current":14.976944,"twenty":4.452456,"median":8.72747,"eighty":13.679972,"marketCap":1606636722},{"date":"2024-10-11","current":14.803637,"twenty":4.452456,"median":8.72747,"eighty":13.85562,"marketCap":1588045302},{"date":"2024-10-18","current":14.529495,"twenty":4.452456,"median":8.72747,"eighty":14.019655,"marketCap":1558637056},{"date":"2024-10-25","current":14.772126,"twenty":4.452456,"median":8.72747,"eighty":14.168401,"marketCap":1584665044},{"date":"2024-11-01","current":14.778428,"twenty":4.452456,"median":8.72747,"eighty":14.27768,"marketCap":1585341095},{"date":"2024-11-08","current":13.141823,"twenty":4.452456,"median":8.73918,"eighty":14.377354,"marketCap":1640493731},{"date":"2024-11-15","current":13.379586,"twenty":4.452456,"median":8.78252,"eighty":14.377354,"marketCap":1670173717},{"date":"2024-11-22","current":14.322533,"twenty":4.452456,"median":8.81344,"eighty":14.377354,"marketCap":1787881840},{"date":"2024-11-29","current":15.251971,"twenty":4.452456,"median":8.883858,"eighty":14.399781,"marketCap":1903903601},{"date":"2024-12-06","current":15.273586,"twenty":4.452456,"median":8.934183,"eighty":14.482822,"marketCap":1906601781},{"date":"2024-12-13","current":14.4198,"twenty":4.452456,"median":9.012663,"eighty":14.537463,"marketCap":1800023652},{"date":"2024-12-20","current":12.93378,"twenty":4.452456,"median":9.090449,"eighty":14.537463,"marketCap":1614523744},{"date":"2024-12-27","current":12.995923,"twenty":4.452456,"median":9.19602,"eighty":14.537463,"marketCap":1622281013},{"date":"2025-01-03","current":12.766265,"twenty":4.452456,"median":9.268408,"eighty":14.537463,"marketCap":1593612846},{"date":"2025-01-10","current":12.631172,"twenty":4.448612,"median":9.31881,"eighty":14.538738,"marketCap":1576749218},{"date":"2025-01-17","current":14.282006,"twenty":4.448612,"median":9.382279,"eighty":14.538738,"marketCap":1782822752},{"date":"2025-01-24","current":13.892938,"twenty":4.448612,"median":9.455255,"eighty":14.538738,"marketCap":1734255503},{"date":"2025-01-31","current":14.63865,"twenty":4.448612,"median":9.481129,"eighty":14.558635,"marketCap":1827342730},{"date":"2025-02-07","current":15.684268,"twenty":4.448612,"median":9.514397,"eighty":14.63454,"marketCap":1957867210},{"date":"2025-02-14","current":15.462716,"twenty":4.448612,"median":9.568033,"eighty":14.675959,"marketCap":1930210860},{"date":"2025-02-21","current":15.732902,"twenty":4.448612,"median":9.580931,"eighty":14.694621,"marketCap":1963938116},{"date":"2025-02-28","current":20.937616,"twenty":4.448612,"median":9.626092,"eighty":14.774647,"marketCap":1933567942},{"date":"2025-03-07","current":19.49754,"twenty":4.444767,"median":9.675026,"eighty":14.838928,"marketCap":1800578330},{"date":"2025-03-14","current":19.960552,"twenty":4.444767,"median":9.675026,"eighty":14.901539,"marketCap":1843337016},{"date":"2025-03-21","current":19.362647,"twenty":4.444767,"median":9.689317,"eighty":15.017908,"marketCap":1788121076},{"date":"2025-03-28","current":19.698057,"twenty":4.444767,"median":9.708699,"eighty":15.110765,"marketCap":1819095871},{"date":"2025-04-04","current":17.87153,"twenty":4.444767,"median":9.75606,"eighty":15.125044,"marketCap":1650417909},{"date":"2025-04-11","current":17.576223,"twenty":4.448612,"median":9.799015,"eighty":15.243459,"marketCap":1623146621},{"date":"2025-04-17","current":18.509538,"twenty":4.448612,"median":9.802712,"eighty":15.283315,"marketCap":1709337357},{"date":"2025-04-25","current":18.910572,"twenty":4.444767,"median":9.80686,"eighty":15.360398,"marketCap":1746372438},{"date":"2025-05-02","current":18.710055,"twenty":4.444767,"median":9.80686,"eighty":15.401794,"marketCap":1727854897},{"date":"2025-05-09","current":14.05872,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1621799891},{"date":"2025-05-16","current":14.406029,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1661865116},{"date":"2025-05-23","current":14.373925,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1658161608},{"date":"2025-05-30","current":15.450609,"twenty":4.444767,"median":9.80686,"eighty":15.444645,"marketCap":1782366767},{"date":"2025-06-06","current":15.621074,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"marketCap":1802031456},{"date":"2025-06-13","current":16.520424,"twenty":4.444767,"median":9.80686,"eighty":15.572999,"marketCap":1905779645},{"date":"2025-06-20","current":16.170677,"twenty":4.440923,"median":9.804164,"eighty":15.627805,"marketCap":1865433127},{"date":"2025-06-27","current":15.57111,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1796267668},{"date":"2025-07-03","current":15.479999,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1785757230},{"date":"2025-07-11","current":15.432974,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1780332488},{"date":"2025-07-18","current":14.992116,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1729475533},{"date":"2025-07-25","current":15.333047,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1768804912},{"date":"2025-08-01","current":15.430035,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1779993442},{"date":"2025-08-08","current":17.700627,"twenty":4.440923,"median":9.82349,"eighty":15.67238,"marketCap":1703526003},{"date":"2025-08-15","current":17.97186,"twenty":4.440923,"median":9.917298,"eighty":15.726991,"marketCap":1729629785},{"date":"2025-08-22","current":17.975383,"twenty":4.440923,"median":9.97212,"eighty":15.765277,"marketCap":1729968795},{"date":"2025-08-29","current":18.669318,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"marketCap":1796753795},{"date":"2025-09-05","current":18.391039,"twenty":4.437079,"median":10.161405,"eighty":15.873833,"marketCap":1769971993},{"date":"2025-09-12","current":18.229004,"twenty":4.440923,"median":10.244717,"eighty":15.951577,"marketCap":1754377526},{"date":"2025-09-19","current":17.911977,"twenty":4.440923,"median":10.348339,"eighty":16.07924,"marketCap":1723866612},{"date":"2025-09-26","current":17.668924,"twenty":4.440923,"median":10.483035,"eighty":16.238322,"marketCap":1700474912},{"date":"2025-10-03","current":16.622738,"twenty":4.440923,"median":10.565798,"eighty":16.310589,"marketCap":1599788897},{"date":"2025-10-10","current":15.678704,"twenty":4.440923,"median":10.601474,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-10-17","current":15.460308,"twenty":4.440923,"median":10.638631,"eighty":16.329708,"marketCap":1487915548},{"date":"2025-10-24","current":16.192991,"twenty":4.440923,"median":10.724558,"eighty":16.329708,"marketCap":1558429659},{"date":"2025-10-31","current":15.978118,"twenty":4.440923,"median":10.745006,"eighty":16.329708,"marketCap":1537750040},{"date":"2025-11-07","current":15.678704,"twenty":4.440923,"median":10.777877,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-11-14","current":18.215203,"twenty":4.440923,"median":10.808766,"eighty":16.403793,"marketCap":1432862540},{"date":"2025-11-21","current":18.438808,"twenty":4.440923,"median":10.856288,"eighty":16.560326,"marketCap":1450451976},{"date":"2025-11-28","current":18.911819,"twenty":4.440923,"median":10.868211,"eighty":16.63112,"marketCap":1487660399},{"date":"2025-12-05","current":19.647135,"twenty":4.440923,"median":10.912667,"eighty":16.757487,"marketCap":1545502583},{"date":"2025-12-12","current":19.023621,"twenty":4.440923,"median":10.960835,"eighty":17.137473,"marketCap":1496455117},{"date":"2025-12-19","current":18.228104,"twenty":4.440923,"median":11.01485,"eighty":17.334253,"marketCap":1433877315},{"date":"2025-12-26","current":18.425908,"twenty":4.440923,"median":11.091519,"eighty":17.554114,"marketCap":1449437201},{"date":"2026-01-02","current":17.995898,"twenty":4.440923,"median":11.134288,"eighty":17.640744,"marketCap":1415611362},{"date":"2026-01-09","current":18.017399,"twenty":4.440923,"median":11.163158,"eighty":17.676428,"marketCap":1417302654},{"date":"2026-01-16","current":19.488032,"twenty":4.440923,"median":11.24834,"eighty":17.766657,"marketCap":1532987023},{"date":"2026-01-23","current":19.139724,"twenty":4.440923,"median":11.32675,"eighty":17.850054,"marketCap":1505588093},{"date":"2026-01-30","current":20.571656,"twenty":4.440923,"median":11.753419,"eighty":17.910997,"marketCap":1618228137},{"date":"2026-02-06","current":20.33085,"twenty":4.440923,"median":12.428533,"eighty":17.953744,"marketCap":1599285667},{"date":"2026-02-09","current":20.184647,"twenty":4.440923,"median":12.42954,"eighty":17.957066,"marketCap":1587784882}],"updateTime":1770727828917},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610625287","title":"Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era","url":"https://stock-news.laohu8.com/highlight/detail?id=2610625287","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610625287?lang=en_us&edition=fundamental","pubTime":"2026-02-10 22:00","pubTimestamp":1770732000,"startTime":"0","endTime":"0","summary":"The new partnership combines Weight Watchers’ scientifically-backed medical and behavioral expertise with PVOLVE’s clinically-studied method to support members at every age and stage of lifeNEW YORK, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/10/3235367/0/en/Weight-Watchers-Partners-with-PVOLVE-to-Deliver-Clinically-Validated-Strength-Workouts-to-Members-in-the-GLP-1-Era.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WW","BK4192","BK4144","GLP","BK4590"],"gpt_icon":0},{"id":"2610634933","title":"Regulatory Overhang on Compounded GLP‑1 Drives Hold Rating and Lowered Outlook for Hims & Hers","url":"https://stock-news.laohu8.com/highlight/detail?id=2610634933","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610634933?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:16","pubTimestamp":1770635774,"startTime":"0","endTime":"0","summary":"Hims & Hers Health, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jonna Kim from TD Cowen maintained a Hold ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/regulatory-overhang-on-compounded-glp‑1-drives-hold-rating-and-lowered-outlook-for-hims-hers-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/regulatory-overhang-on-compounded-glp‑1-drives-hold-rating-and-lowered-outlook-for-hims-hers-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP"],"gpt_icon":0},{"id":"2610686857","title":"Dow Jones Top Company Headlines at 1 AM ET: Health Agency Refers Knockoff GLP-1 Provider Hims & Hers to Justice Department | Innovent ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2610686857","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610686857?lang=en_us&edition=fundamental","pubTime":"2026-02-09 14:00","pubTimestamp":1770616800,"startTime":"0","endTime":"0","summary":"Health Agency Refers Knockoff GLP-1 Provider Hims & Hers to Justice Department. The FDA said it would take \"decisive steps\" to restrict nonapproved drugs that use GLP-1 active pharmaceutical ingredients.Innovent Biologics Strikes Partnership Deal With Eli Lilly. Chinese drugmaker Innovent Biologics and Eli Lilly plan to target cancer and immune system diseases under the partnership.Elon Musk's rocket company had aimed to reach the red planet in 2026. A Critical AI Niche Is Dominated by One Little-Known Japanese Company. The century-old former silk spinner pioneered a cloth-like material made from glass fibers. Now a shortage is looming over the artificial-intelligence boom.Uber Ordered to Pay $8.5 Million in Passenger Sexual Assault Case. A jury found the company liable for the 2023 sexual assault of a 19-year-old passenger.Kroger Plans to Name an Ex-Walmart Executive as Its Next CEO. Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe. As it probes bids f","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","IE00BZ18W340.USD","GLP","AM","BK4590","BK4144","BK4585","IE00BZ18W456.USD","BK4561","IE00BMQBXF63.USD","BK4588","ET"],"gpt_icon":0},{"id":"2609172245","title":"Dow Jones Top Company Headlines at 7 PM ET: FDA Targets Hims & Hers, Other Marketers of Unapproved GLP-1 Weight-Loss Drugs | Justice ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2609172245","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609172245?lang=en_us&edition=fundamental","pubTime":"2026-02-07 08:00","pubTimestamp":1770422400,"startTime":"0","endTime":"0","summary":"FDA Targets Hims & Hers, Other Marketers of Unapproved GLP-1 Weight-Loss Drugs. The FDA said it would take \"decisive steps\" to restrict non-approved drugs that use GLP-1 active pharmaceutical ingredients.Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe. As it probes bids for Warner, the department is asking if the streamer has engaged in conduct that could make it a monopoly.Elon Musk's rocket company had aimed to reach the red planet in 2026. Jeep Maker Stellantis Books $26 Billion Charges in EV Reset. The charges are the most costly yet reported by an automaker related to bad bets on EVs. The company's Europe-listed shares fell more than 20%.Hobbit-Inspired Startup Becomes First New Bank Greenlighted by Trump 2.0. Carlyle Profit Rises as Management Signals Minimal Hit from Software Turmoil. Software 'is not a piston in the engine' of the firm's growth, executives say, noting it represents 6% of assets under management.Uber Ordered to Pay $8.5 Million ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","BK4561","ET","GLP","BK4144","BK4588","BK4590"],"gpt_icon":0},{"id":"2609699512","title":"FDA intends to ‘take action’ against non-FDA-approved GLP-1 drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2609699512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609699512?lang=en_us&edition=fundamental","pubTime":"2026-02-07 06:00","pubTimestamp":1770415227,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration announced its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients intended for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-intends-to-take-action-against-non-fda-approved-glp-1-drugs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-intends-to-take-action-against-non-fda-approved-glp-1-drugs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP","BK4590","BK4144"],"gpt_icon":0},{"id":"2609562307","title":"Embecta: Stable Execution, GLP-1–Driven Growth Optionality, and Attractive Valuation Support Buy Rating and $25 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2609562307","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609562307?lang=en_us&edition=fundamental","pubTime":"2026-02-06 18:45","pubTimestamp":1770374750,"startTime":"0","endTime":"0","summary":"BTIG analyst Marie Thibault reiterated a Buy rating on Embecta Corporation on February 3 and set a price target of $25.00. Marie Thibault has given...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/embecta-stable-execution-glp-1-driven-growth-optionality-and-attractive-valuation-support-buy-rating-and-25-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/embecta-stable-execution-glp-1-driven-growth-optionality-and-attractive-valuation-support-buy-rating-and-25-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP"],"gpt_icon":0},{"id":"2609536866","title":"LifeVantage Earnings Call: GLP-1 Hit Tests Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2609536866","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609536866?lang=en_us&edition=fundamental","pubTime":"2026-02-06 08:14","pubTimestamp":1770336891,"startTime":"0","endTime":"0","summary":"LifeVantage Corp (($LFVN)) has held its Q2 earnings call. Read on for the main highlights of the call. LifeVantage Earnings Call Balances Strategic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lifevantage-earnings-call-glp-1-hit-tests-turnaround?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lifevantage-earnings-call-glp-1-hit-tests-turnaround?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP"],"gpt_icon":0},{"id":"2609930848","title":"Edible Garden to Participate in ECRM’s Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, February 10–12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2609930848","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609930848?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:09","pubTimestamp":1770296940,"startTime":"0","endTime":"0","summary":"BELVIDERE, NJ, Feb.  05, 2026  (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/05/3232972/0/en/Edible-Garden-to-Participate-in-ECRM-s-Total-Wellness-GLP-1-Weight-Management-Nutrition-Vitamin-Session-February-10-12-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4500","BK4590","BK4144","GLP","TSS","CEA","BK4008"],"gpt_icon":0},{"id":"2609631791","title":"Press Release: GLP China Holdings Limited TENDER OFFER TO PURCHASE FOR CASH ANY AND ALL OF ITS U.S.$700,000,000 2.95 PER CENT. NOTES DUE 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2609631791","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609631791?lang=en_us&edition=fundamental","pubTime":"2026-02-05 08:29","pubTimestamp":1770251340,"startTime":"0","endTime":"0","summary":"HONG KONG, Feb. 4, 2026 /PRNewswire/ -- GLP China Holdings Limited ( ) , has mandated Morgan Stanley as dealer manager  in relation to the cash tender offer  to purchase any and all of its outstanding U.S.$700,000,000 2.95 per cent. Notes due 2026  .Capitalised terms used but not defined herein have the meanings assigned in the Tender Offer Memorandum.Description of    Acceptance    ISIN / Common     Principal     Purchase Price. U.S.$700,000,0  Any and all     XS2314779427 /  U.S.$495,000,0  U.S.$1,000","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GLP","LU0267386448.USD","LU1732799900.SGD","LU1989772923.USD","LU2347655156.SGD","BK4533","BK4590","LU2271345857.HKD","LU2355687059.USD","LU0098860793.USD","LU0971096721.USD","BK4018","LU1732800096.USD","LU1791710400.SGD","BK4024","BK4516","LU1548497426.USD","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU0985320562.USD","LU1074936037.SGD","ALL","BK4504","CENT","FOR","LU0795875169.SGD","LU1571399168.USD","LU1720051108.HKD","LU2089283258.USD","BK4534","LU0528227936.USD","BK4107","LU0106831901.USD","LU2089284900.SGD","LU0912757837.SGD","LU2357305700.SGD","LU0234570918.USD","LU2028103732.USD","IE00BKVL7J92.USD","LU0882574139.USD","LU0158827781.USD","ANY","LU2111349929.HKD","LU0320765646.SGD","LU1244550221.USD","LU0106261372.USD","BK4144","CASH","BK4097"],"gpt_icon":0},{"id":"2608384544","title":"PepsiCo Charts Growth Amid GLP-1, Ad Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2608384544","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608384544?lang=en_us&edition=fundamental","pubTime":"2026-02-04 08:14","pubTimestamp":1770164063,"startTime":"0","endTime":"0","summary":"Pepsico (($PEP)) has held its Q4 earnings call. Read on for the main highlights of the call. Management struck a cautiously upbeat tone, leaning on...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pepsico-charts-growth-amid-glp-1-ad-headwinds?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pepsico-charts-growth-amid-glp-1-ad-headwinds?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP","PEP"],"gpt_icon":0},{"id":"2608072190","title":"Is It Time To Reassess Global Partners (GLP) After Big Five Year Share Gains?","url":"https://stock-news.laohu8.com/highlight/detail?id=2608072190","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608072190?lang=en_us&edition=fundamental","pubTime":"2026-01-31 21:21","pubTimestamp":1769865696,"startTime":"0","endTime":"0","summary":"If you are wondering whether Global Partners' share price still offers value after past gains and recent swings, starting with a clear look at its current valuation can help frame your next move.\nOver shorter periods the stock has had mixed returns, with 6.7% over the past week, 12.8% over the past month, 11.7% year to date, a 7.3% decline over the past year and a very large gain of about 2.4x over five years.\nRecent price moves sit against a backdrop of ongoing interest in energy...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551704-choice2-main-header/1585186816500","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551704-choice2-main-header/1585186816500"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/energy/nyse-glp/global-partners/news/is-it-time-to-reassess-global-partners-glp-after-big-five-ye","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-glp/global-partners/news/is-it-time-to-reassess-global-partners-glp-after-big-five-ye","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4144","BK4590","DCF","GLP"],"gpt_icon":0},{"id":"2607004597","title":"Press Release: Global Partners Declares Fourth-Quarter 2025 Cash Distribution of $0.7600 on Common Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2607004597","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607004597?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779800,"startTime":"0","endTime":"0","summary":"Global Partners LP   today announced that the Board of Directors of its general partner, Global GP LLC, has declared a cash distribution of $0.7600 per unit  on all of its outstanding common units for the period from October 1, 2025 through December 31, 2025. The distribution will be paid on February 13, 2026 to unitholders of record as of the close of business on February 9, 2026.Global Partners, a master limited partnership, trades on the New York Stock Exchange under the ticker symbol \"GLP.\" For additional information, visit www.globalp.com.Certain statements and information in this press release","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK4144","GLP"],"gpt_icon":0},{"id":"2607399038","title":"Fractyl Health Advances Revita for Post-GLP-1 Weight Maintenance","url":"https://stock-news.laohu8.com/highlight/detail?id=2607399038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607399038?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:38","pubTimestamp":1769693927,"startTime":"0","endTime":"0","summary":"Fractyl Health, Inc. ( ($GUTS) ) has issued an announcement. On January 29, 2026, Fractyl Health reported six-month randomized interim data from it...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fractyl-health-advances-revita-for-post-glp-1-weight-maintenance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fractyl-health-advances-revita-for-post-glp-1-weight-maintenance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4590","GUTS","BK4212","GLP","POST","BK4144"],"gpt_icon":0},{"id":"2606403790","title":"Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users","url":"https://stock-news.laohu8.com/highlight/detail?id=2606403790","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606403790?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:00","pubTimestamp":1769598000,"startTime":"0","endTime":"0","summary":"Nugevia supports metabolic, mitochondrial, and neuroinflammatory biology impacted by GLP-1-driven weight loss Jupiter, Florida, Jan.  28, 2026  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/28/3227379/0/en/Jupiter-Neurosciences-Expands-Nugevia-Addressable-Market-with-Focus-on-GLP-1-Users.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","BK4590","BK4135","GLP","BK4007","JUNS","CNS"],"gpt_icon":0},{"id":"1117243250","title":"Huadong Medicine: HDM1002, as a differentiated oral GLP-1 targeted drug, is positioned to meet unmet and differentiated clinical needs in the global market","url":"https://stock-news.laohu8.com/highlight/detail?id=1117243250","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117243250?lang=en_us&edition=fundamental","pubTime":"2026-01-27 19:41","pubTimestamp":1769514072,"startTime":"0","endTime":"0","summary":"On January 27, Huadong Medicine Co.,Ltd. responded to investor inquiries on an interactive platform, stating that HDM1002, as a differentiated oral GLP-1 targeted drug, is specifically positioned to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","BK0183","BK0209","BK0187","BK0188","000963","BK0175","GLP","BK0132","BK4144","LU2328871848.SGD","BK0196","BK4590"],"gpt_icon":0},{"id":"1103679046","title":"Roche Reports Positive Phase II Trial Results for GLP-1/GIP Dual Receptor Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1103679046","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103679046?lang=en_us&edition=fundamental","pubTime":"2026-01-27 17:00","pubTimestamp":1769504439,"startTime":"0","endTime":"0","summary":"Swiss pharmaceutical giant Roche announced on Tuesday that its investigational GLP-1/GIP dual receptor agonist, CT-388, has achieved positive results in a Phase II clinical trial for the treatment of obesity.\n","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","BK4590","BK4144"],"gpt_icon":0},{"id":"1115934877","title":"ASCLETIS-B (01672) Announces Completion of First Dosing in 13-Week US Phase II Study of Oral Small-Molecule GLP-1R Agonist ASC30 for Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=1115934877","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115934877?lang=en_us&edition=fundamental","pubTime":"2026-01-26 08:26","pubTimestamp":1769387173,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that its Board of Directors declared the completion of the first patient dosing in a 13-week US Phase II study (NCT07321678) of its oral small-molecule GLP-1 receptor...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1574","BK1161","BK1515","GLP","BK4144","BK4590","BK1191","01477"],"gpt_icon":0},{"id":"2606617792","title":"Ascletis Starts U.S. Phase II Diabetes Trial of Oral GLP-1 Drug ASC30 After Strong Obesity Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2606617792","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606617792?lang=en_us&edition=fundamental","pubTime":"2026-01-26 08:07","pubTimestamp":1769386045,"startTime":"0","endTime":"0","summary":"Ascletis Pharma, Inc. ( ($HK:1672) ) just unveiled an announcement. Ascletis Pharma has begun dosing the first participants in a 13-week, randomize...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ascletis-starts-u-s-phase-ii-diabetes-trial-of-oral-glp-1-drug-asc30-after-strong-obesity-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ascletis-starts-u-s-phase-ii-diabetes-trial-of-oral-glp-1-drug-asc30-after-strong-obesity-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP","BK4144","BK4590"],"gpt_icon":0},{"id":"1158406293","title":"ASCLETIS-B (01672) Selects Next-Generation Monthly Subcutaneous GLP-1R/GIPR/GCGR Triple Agonist Peptide ASC37 for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1158406293","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158406293?lang=en_us&edition=fundamental","pubTime":"2026-01-20 17:56","pubTimestamp":1768903007,"startTime":"0","endTime":"0","summary":"The Board of ASCLETIS-B (01672) announced that it has selected ASC37, a next-generation, once-monthly, subcutaneously administered GLP-1R/GIPR/GCGR triple agonist peptide, as a clinical development...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK4160","01477","BK1191","BK1574","01672","BK4590","GLP","GIPR","BK1161","BK4144"],"gpt_icon":0},{"id":"2604195420","title":"Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2604195420","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604195420?lang=en_us&edition=fundamental","pubTime":"2026-01-20 17:00","pubTimestamp":1768899600,"startTime":"0","endTime":"0","summary":"- In head-to-head non-human primate  studies, average observed half-life of ASC37 was approximately 17 days, 7-fold longer than retatrutide, which supports once-monthly subcutaneous  dosing in humans.- ASC37's average in vitro activity was approximately 5-, 4-, and 4-fold more potent than retatrutide for GLP-1R, GIPR and GCGR, respectively.- Submission of an Investigational New Drug Application  to the U.S. Food and Drug Administration  for ASC37 injection is expected in the second quarter of 2026.HONG KONG, Jan. 20, 2026 /PRNewswire/ -- Ascletis Pharma Inc.  announces that it has selected ASC37 injection, a next-generation, once-monthly, subcutaneously administered GLP-1R/GIPR/GCGR[1] triple peptide agonist, as a clinical development candidate. Ascletisexpects to submit an Investigational New Drug Applicationto the U.S. Food and Drug Administrationfor ASC37 injection for the treatment of obesity in the second quarter of 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ascletis-selects-a-next-generation-once-monthly-subcutaneously-administered-glp-1rgiprgcgr-triple-peptide-agonist-asc37-for-clinical-development-302665199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4160","IND","BK7095","GLP","BK4144","IND.AU","BK4590"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}]}}